Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants

Indirect Hyperbilirubinemia Clinical Trial

Official title: Phase 4 Study of Saccharomyces Boulardii on Indirect Hyperbilirubinemia

Status Recruiting

Clinical Trial Summary

Indirect hyperbilirubinemia is frequently observed in premature infants.Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system. In this study we aimed to compare the effect of S. boulardii on severity of hyperbilirubinemia and duration of phototherapy on very low birth weight infants.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Hyperbilirubinemia
• Indirect Hyperbilirubinemia

• NCT number: NCT01411761
• Study type: Interventional
• Source: Zekai Tahir Burak Women's Health Research and Education Hospital
• Contact: Gamze Demirel, MD
• Phone: +905324540156
• Email: kgamze@hotmail.com
• Status: Recruiting
• Phase: Phase 4
• Start date: May 2011
• Completion date: December 2011